COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran

An update to “novel therapeutic approaches for treatment of COVID-19”

(2021) Nikoo Hossein-khannazer et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Willingness to be vaccinated against COVID-19: an exploratory online survey in a Portuguese cohort of multiple sclerosis patients

(2021) Filipa Serrazina et al.   Multiple Sclerosis and Related Disorders

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis

(2021) Amber Salter et al.   JAMA Neurology

Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States

(2021) Dawn M. Ehde et al.   Multiple Sclerosis and Related Disorders

E-health roadmap for COVID-19 vaccine coverage in Iran

(2021) Elham Maserat et al.   BMC PUBLIC HEALTH

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic

(2021) Tobias Monschein et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey

(2021) Lauren Uhr et al.   Multiple Sclerosis Journal

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV

(2021) Mohammad Ali Sahraian et al.   VACCINE

Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia

(2021) Amar Ibrahim Omer Yahia et al.   Human Vaccines & Immunotherapeutics

National Vaccination and Local Intervention Impacts on COVID-19 Cases

(2021) Toni Toharudin et al.   Sustainability

Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations

(2021) Maria Giulia Salomoni et al.   Vaccines

The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: “Vaccination Refusal Could Prolong the War of This Pandemic” – A Systematic Review

(2021) Addisu Dabi Wake   Risk Management and Healthcare Policy

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey

(2021) Yun Huang et al.   Multiple Sclerosis and Related Disorders

SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021

(2021) Zahra Heydarifard et al.   VIROLOGICA SINICA

Vaccine hesitancy: the next challenge in the fight against COVID-19

(2020) Amiel A. Dror et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study

(2020) Mohamad Nikpouraghdam et al.   JOURNAL OF CLINICAL VIROLOGY

Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults

(2020) Kimberly A. Fisher et al.   ANNALS OF INTERNAL MEDICINE

Therapeutic Modalities and Novel Approaches in Regenerative Medicine for COVID-19

(2020) Roya Ramezankhani et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

(2020) Paul L. Reiter et al.   VACCINE

Vaccine hesitancy: Definition, scope and determinants

(2015) Noni E. MacDonald   VACCINE